{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T05:53:59Z","timestamp":1781243639516,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.clon.2023.01.017","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T22:36:39Z","timestamp":1675118199000},"page":"516-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Improving Quality of Life with Brachytherapy for Urological Malignancies"],"prefix":"10.1016","volume":"35","author":[{"given":"D.","family":"Scheltes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"van der Steen-Banasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2023.01.017_bib1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.radonc.2021.12.047","article-title":"GEC-ESTRO ACROP prostate brachytherapy guidelines","volume":"167","author":"Henry","year":"2022","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2023.01.017_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.brachy.2011.07.005","article-title":"American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy","volume":"11","author":"Davis","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.clon.2023.01.017_bib3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.eururo.2017.06.035","article-title":"Quality of life outcomes after primary treatment for clinically localised prostate cancer: a systematic review","volume":"72","author":"Lardas","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.clon.2023.01.017_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.urolonc.2022.04.008","article-title":"Patient reported outcomes and health related quality of life in localized prostate cancer: a review of current evidence","volume":"40","author":"Kord","year":"2022","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.clon.2023.01.017_bib5","doi-asserted-by":"crossref","first-page":"540","DOI":"10.5114\/jcb.2020.101686","article-title":"Ten-year longitudinal health-related quality of life following iodine-125 brachytherapy monotherapy for localized prostate cancer","volume":"12","author":"Slevin","year":"2020","journal-title":"J\u00a0Contemp Brachyther"},{"key":"10.1016\/j.clon.2023.01.017_bib6","doi-asserted-by":"crossref","first-page":"m3503","DOI":"10.1136\/bmj.m3503","article-title":"Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study","volume":"371","author":"Mazariego","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.clon.2023.01.017_bib7","first-page":"56","article-title":"Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment","volume":"36","author":"Seymour","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.clon.2023.01.017_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/COC.0000000000000796","article-title":"Patient-reported quality of life after SBRT, LDR, and HDR brachytherapy for prostate cancer: a comparison of outcomes","volume":"44","author":"Paly","year":"2021","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clon.2023.01.017_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","volume":"98","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2023.01.017_bib10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.radonc.2020.09.047","article-title":"Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: mature 12-year results","volume":"154","author":"Hoskin","year":"2021","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.clon.2023.01.017_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.clon.2013.01.001","article-title":"Quality of life after radical radiotherapy for prostate cancer: longitudinal study from a randomised trial of external beam radiotherapy alone or in combination with high dose rate brachytherapy","volume":"25","author":"Hoskin","year":"2013","journal-title":"Clin Oncol"},{"issue":"2","key":"10.1016\/j.clon.2023.01.017_bib12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijrobp.2017.01.008","article-title":"ASCENDE-RT: an analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Rodda","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2023.01.017_bib13","first-page":"6165","article-title":"High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer","volume":"11","author":"Yamazaki","year":"2021","journal-title":"Nat Sci Rep"},{"key":"10.1016\/j.clon.2023.01.017_bib14","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.brachy.2021.07.005","article-title":"Patient-reported outcomes after low-dose-rate versus high-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer","volume":"20","author":"Dhere","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.clon.2023.01.017_bib15","series-title":"EAU guidelines on muscle-invasive and metastatic bladder cancer","author":"Witjes","year":"2022"},{"issue":"6","key":"10.1016\/j.clon.2023.01.017_bib16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.5114\/jcb.2020.101697","article-title":"Perpetual role of brachytherapy in organ-sparing treatment for bladder cancer: a historical review","volume":"12","author":"Van der Steen-Banasik","year":"2020","journal-title":"J\u00a0Contemp Brachyther"},{"issue":"3","key":"10.1016\/j.clon.2023.01.017_bib17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.radonc.2016.12.022","article-title":"GEC-ESTRO\/ACROP recommendations for performing bladder-sparing treatment with brachytherapy for muscle-invasive bladder carcinoma","volume":"122","author":"Pieters","year":"2017","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.clon.2023.01.017_bib18","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1093\/annonc\/mds126","article-title":"Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumors","volume":"23","author":"Koning","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2023.01.017_bib19","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.radonc.2009.04.020","article-title":"Brachytherapy versus cystectomy in solitary bladder cancer: a case control, multicentre, East Netherlands study","volume":"93","author":"van der Steen-Banasik","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2023.01.017_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.radonc.2019.09.026","article-title":"Long-term survival and complications following bladder-preserving brachytherapy in patients with cT1-T2 bladder cancer","volume":"141","author":"Voskuilen","year":"2019","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.clon.2023.01.017_bib21","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/bju.15047","article-title":"Overall survival, disease-specific survival and local recurrence outcomes in patients with muscle-invasive bladder cancer treated with external beam radiotherapy and brachytherapy: a systematic review","volume":"125","author":"Mannion","year":"2020","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.clon.2023.01.017_bib22","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.ijrobp.2016.03.029","article-title":"The Curie-Da Vinci Connection: 5-years' experience with laparoscopic (robot-assisted) implantation for high-dose-rate brachytherapy of solitary T2 bladder tumors","volume":"95","author":"Van der Steen-Banasik","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.clon.2023.01.017_bib23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.eururo.2017.05.054","article-title":"Robot-assisted laparoscopic implantation of brachytherapy catheters in bladder cancer","volume":"74","author":"Bosschieter","year":"2018","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clon.2023.01.017_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5114\/jcb.2017.69548","article-title":"Robot-assisted brachytherapy of the bladder with long distance support using video conferencing","volume":"9","author":"Mascarenhas","year":"2017","journal-title":"J\u00a0Contemp Brachyther"},{"key":"10.1016\/j.clon.2023.01.017_bib25","doi-asserted-by":"crossref","DOI":"10.5114\/jcb.2023.127050","article-title":"Quality of life of muscle invasive bladder cancer patients who were treated with brachytherapy, a cross sectional study","author":"Scheltes","year":"2023","journal-title":"J Contemp Brachyther"},{"issue":"5","key":"10.1016\/j.clon.2023.01.017_bib26","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ijrobp.2016.08.023","article-title":"Quality of life in long-term survivors of muscle invasive\u00a0bladder cancer","volume":"96","author":"Mak","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clon.2023.01.017_bib27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.eururo.2021.01.032","article-title":"Quality of life after bladder cancer: a cross sectional survey of patient reported outcomes","volume":"79","author":"Catto","year":"2021","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clon.2023.01.017_bib28","first-page":"1105","article-title":"Quality of life for patients treated for penile cancer","volume":"192","author":"Kieffer","year":"2014","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clon.2023.01.017_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2490-9-8","article-title":"Identifying the needs of penile cancer sufferers: a systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer","volume":"9","author":"Maddineni","year":"2009","journal-title":"BMC Urol"},{"issue":"5","key":"10.1016\/j.clon.2023.01.017_bib30","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1464-410X.1994.tb09200.x","article-title":"Quality of life in patients treated for penile cancer. A follow-up study","volume":"74","author":"Opjordsmoen","year":"1994","journal-title":"Br J Urol"},{"issue":"2","key":"10.1016\/j.clon.2023.01.017_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00345-008-0312-x","article-title":"Penile preserving surgery and surgical strategies to maximize penile form and function in penile cancer: recommendations from the United Kingdom experience","volume":"27","author":"Hegarty","year":"2009","journal-title":"World J Urol"},{"issue":"4","key":"10.1016\/j.clon.2023.01.017_bib32","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.ijrobp.2008.09.054","article-title":"Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX)","volume":"74","author":"de Crevoisier","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clon.2023.01.017_bib33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","article-title":"EAU guidelines on penile cancer: 2014 update","volume":"67","author":"Hakenberg","year":"2015","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clon.2023.01.017_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.eururo.2008.04.016","article-title":"Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients","volume":"54","author":"Leijte","year":"2008","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clon.2023.01.017_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brachy.2017.09.006","article-title":"Long-term evaluation of urinary, sexual, and quality of life outcomes after brachytherapy for penile carcinoma","volume":"17","author":"Gambachidze","year":"2018","journal-title":"Brachytherapy"},{"issue":"4","key":"10.1016\/j.clon.2023.01.017_bib36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.brachy.2013.06.001","article-title":"Brachytherapy for penile cancer: efficacy and impact on sexual function","volume":"13","author":"Delaunay","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.clon.2023.01.017_bib37","first-page":"89","article-title":"High-dose rate brachytherapy in localized penile cancer: 5-year clinical outcome analysis","volume":"27","author":"Martz","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.clon.2023.01.017_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2051-4190-24-13","article-title":"Evaluation of sexual functions and sexual behaviors after penile brachytherapy in men treated for penile carcinoma","volume":"24","author":"Soh","year":"2014","journal-title":"Basic Clin Androl"},{"issue":"6","key":"10.1016\/j.clon.2023.01.017_bib39","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.21037\/tau-20-1228","article-title":"Sexual function in the penile cancer survivor: a narrative review","volume":"10","author":"Stroie","year":"2021","journal-title":"Transl Androl Urol"},{"issue":"2","key":"10.1016\/j.clon.2023.01.017_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0167-8140(95)01574-Z","article-title":"Interstitial brachytherapy for penile carcinoma: a multicentric survey (259 patients)","volume":"36","author":"Rozan","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2023.01.017_bib41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1748-717X-9-142","article-title":"High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis","volume":"9","author":"Rouscoff","year":"2014","journal-title":"Radiat Oncol"},{"issue":"5","key":"10.1016\/j.clon.2023.01.017_bib42","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.brachy.2014.06.003","article-title":"High-dose-rate interstitial brachytherapy for T1-T2-stage penile carcinoma: short-term results","volume":"13","author":"Sharma","year":"2014","journal-title":"Brachytherapy"},{"issue":"7","key":"10.1016\/j.clon.2023.01.017_bib43","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00066-016-0968-x","article-title":"Organ-sparing treatment of penile cancer with interstitial pulsed-dose-rate brachytherapy. Organschonende Behandlung beim Peniskarzinom mittels interstitieller \u201cPulsed-dose-rate\u201d-Brachytherapie","volume":"192","author":"Seibold","year":"2016","journal-title":"Strahlenther Onkol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655523000225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655523000225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:52:58Z","timestamp":1760543578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655523000225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0936655523000225"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2023.01.017","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving Quality of Life with Brachytherapy for Urological Malignancies","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2023.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}